Emerging Biotech Peer Exchange: Building CMC Strategies with Limited Resources
1:00 pm - Friday 19th February 2027
For emerging RNA developers, deciding where to invest limited CMC resources can be just as challenging as the technical development itself.
Designed as an informal, networking session, this peer exchange offers early-stage biotech teams the opportunity to connect with others facing similar challenges, share lessons learned and exchange practical advice in an open, collaborative setting.
An interactive discussion for early-stage mRNA developers to compare how they are:
- Deciding when to invest in internal CMC capabilities versus external support
- Prioritising spend across process development, assay development and regulatory preparation
- Selecting CDMOs and consultants that understand the needs of smaller companies
- Avoiding early development decisions that create expensive problems later
